advertisement

Topcon

Doan LV 16

Showing records 1 to 16 | Display all abstracts from Doan LV

116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Berdahl JP
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarkisian SR
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarkisian SR
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Ang RE
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Ang RE
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Lee AM
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Doan LV; Doan LV
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Berdahl JP; Heersink SB
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Kothe AC
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Burden JH
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Usner DW
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Doan LV; Doan LV
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Katz LJ; Navratil T
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Stephens KG
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension

Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Kothe AC; Usner DW; Katz LJ; Navratil T;
Ophthalmology 2024; 131: 1021-1032

Issue 24-4

Change Issue


advertisement

Nidek